[A cross-sectional study on metabolic syndrome and its abnormal components in cancer patients].

Affiliation

Gao Y(1), Sun SM(1), Fan N(2), Wei W(1), Zhang Q(1).
Author information:
(1)Health Management Center, Tianjin Medical University General Hospital, Tianjin 300052, China.
(2)School of Public Health, Tianjin Medical University, Tianjin 300070, China.

Abstract

From December 2017 to December 2018, 3 509 subjects who had regular physical examination in Health Management Center, Tianjin Medical University General Hospital were enrolled in our study, including 399 cancer patients, 1 555 chronic disease patients, and 1 555 healthy control, respectively. The mean age was (55.87±11.98) years, and 31.38% were men. The prevalence of MS among chronic disease group (42.44%) was higher than that of cancer group (34.59%) and healthy control group (18.65%) (P<0.001). Compared with healthy control group, the OR (95%CI) values of MS risk in cancer group and chronic disease group were 2.13 (1.61-2.83) and 2.85 (2.23-3.66), respectively; the OR (95%CI) values of MS risk were 3.56 (2.04-6.21) and 2.77 (1.46-5.25) in breast cancer and thyroid cancer, respectively.